1987 Volume 16 Issue 2 Pages 881-884
Dynamics of β2-microglobulin (β2-MG) was studied in patients on blood purification comparing various dialyzers. Serum β2-MG was significantly lower in CAPD patients than in hemodialysis (HD) and hemofiltration (HF) patients, maybe due to the short period of treatment on CAPD. The accumulation of serum β2-MG did not correlate with period of treatment, serum creatinine and type of dialyzer. Serum β2-MG was removed during treatment with HD on EVAL membrane and HF, but its concentration before treatment was comparable. Long-term use of EVAL membrane seemed to suppress or reduce serum β2-MG accumulation. β-glucan eluted from cuprophan membrane was not related to β2-MG production.
